Journal article
Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
- Abstract:
-
Study question: How safe is live attenuated influenza vaccine (LAIV), which contains egg protein, in young people with egg allergy? Methods: In this open label, phase IV intervention study, 779 young people (2-18 years) with egg allergy were recruited from 30 UK allergy centres and immunised with LAIV. The cohort included 270 (34.7%) young people with previous anaphylaxis to egg, of whom 157 (20.1%) had experienced respiratory and/or cardiovascular symptoms.... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 321.9KB)
-
- Publisher copy:
- 10.1136/bmj.h6291
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
+ Department of Health
More from this funder
Grant:
National Vaccine Evaluation Consortium, 039/0031
Bibliographic Details
- Publisher:
- BMJ Publishing Group Publisher's website
- Journal:
- BMJ Journal website
- Volume:
- 351
- Article number:
- h6291
- Publication date:
- 2015-01-01
- Acceptance date:
- 2015-11-05
- DOI:
- EISSN:
-
1756-1833
- Source identifiers:
-
610249
Item Description
- Pubs id:
-
pubs:610249
- UUID:
-
uuid:0094eee6-3cb2-406c-95ba-08a11e07d618
- Local pid:
- pubs:610249
- Deposit date:
- 2016-03-16
Terms of use
- Copyright holder:
- BMJ Publishing Group Ltd
- Copyright date:
- 2015
- Notes:
- This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record